Atorvastatin Calcium
Product Images NDC 58517-001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 58517-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by New Horizon Rx Group, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E8f80f38-figure-01 (E8f80f38 Figure 01)

E8f80f38-figure-01 (E8f80f38 Figure 01)
Chemical structure of atorvastatin calcium, showing the molecular configuration including calcium ions as part of the compound.*
FDA Label Image

E8f80f38-figure-02 (E8f80f38 Figure 02)

E8f80f38-figure-02 (E8f80f38 Figure 02)
A line graph displaying cumulative incidence percentages over time (up to 3.5 years) for two groups labeled Atorvastatin and Placebo. The Atorvastatin group shows a consistently lower cumulative incidence compared to the Placebo group. The graph includes a hazard ratio (HR=0.64) with confidence intervals and a p-value below 0.001, indicating statistical data related to the comparison of these two treatments.*
FDA Label Image

E8f80f38-figure-03 (E8f80f38 Figure 03)

E8f80f38-figure-03 (E8f80f38 Figure 03)
A line graph comparing the cumulative hazard percentage over time for placebo versus atorvastatin across a follow-up period of up to 5 years. The graph shows lower cumulative hazard for atorvastatin compared to placebo, with hazard ratio and p-value noted on the chart.*
FDA Label Image

E8f80f38-figure-04 (E8f80f38 Figure 04)

E8f80f38-figure-04 (E8f80f38 Figure 04)
A line graph comparing the percentage of subjects experiencing an event over time for Atorvastatin 10 mg and 80 mg. The x-axis shows time to first major cardiovascular endpoint in years, ranging from 0 to 5 years. The y-axis shows the percentage of subjects experiencing the event, ranging from 0 to 0.2%. The graph includes hazard ratio statistics indicating HR 0.78 (0.69-0.89) with a p-value of 0.0002.*
FDA Label Image

E8f80f38-figure-05 (E8f80f38 Figure 05)

E8f80f38-figure-05 (E8f80f38 Figure 05)
Atorvastatin Calcium Tablets 40 mg bottle label from New Horizon Rx Group, LLC. The label states 30 tablets per container and includes storage instructions, dispensing warnings, and manufacturer details. It displays the NDC 58517-001-30 and indicates prescription use only (Rx only).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.